Lonza sells lipid oral dosage facilities to NextPharma in softgel market exit

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

01 Mar 2021 --- US-based Youtheory has launched a collagen combo line of five products, which harness the impact of hydrolyzed collagen and other clinically studied ingredients... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

24 Feb 2021 --- The category of performance nutraceuticals has undergone a dramatic shift in the last decade. Products traditionally aimed at boosting athletic enhancement have... Read More

FormattedPicture

PACKAGING & TECHNOLOGY NEWS

11 Feb 2021 --- Catalent is launching CosmoPod Duo, a softgel capsule for the delivery of topical skin treatments. Based on the company’s CosmoPod unit-dose twist-off... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

10 Feb 2021 --- Lonza’s Specialty Ingredients business has been acquired by Bain Capital and Cinven for an enterprise value of CHF 4.2 billion (US$4.7 billion).“The... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

27 Jan 2021 --- Lonza has reported a “strong” performance for its 2020 financial year. Notably, the Capsules & Health Ingredients segment benefited from increased... Read More

trans